Ramírez-Del Pilar R, Sánchez ÁE, Alemán-Domínguez D, López-González DS, Matamoros-Mejía AP, Salgado-Muñoz TG, Terán-González JO, Reyes-Jiménez AE, Castro-D´ Franchis LJ

Idioma: Español
Referencias bibliográficas: 16
Paginas: 455-460
Archivo PDF: 419.39 Kb.

RESUMEN

Comunicamos el caso de un paciente de 71 años de edad con manifestación dermatológica como signo inicial de síndrome mielodisplásico, caracterizado por inicio súbito de fiebre, leucocitosis y lesiones cutáneas (pápulas, placas o nódulos eritematosos, bien delimitados, sensibles al tacto, con o sin vesículas; en términos histológicos, con infiltrado neutrofílico en la dermis papilar, sin vasculitis leucocitoclástica). El 20% de los casos se asocia con enfermedades malignas, como en este paciente; de éstas 80% son hematológicas (policitemia vera, síndrome mielodisplásico y leucemia mieloide aguda).

REFERENCIAS (EN ESTE ARTÍCULO)

1. Cohen PR. Sweet’s syndrome– a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007;34:1-28.

2. Wallach D. Neutrophilic dermatoses. Rev Med Interne 2005;26:41-53.

3. Abbas O, Kibbi AG, Rubeiz N. Sweet’s syndrome: retrospective study of clinical and histologic features of 44 cases from a tertiary care center. Int J Dermatol 2010;49:1244-1249.

4. Bourke JF, Keohane S, Long CC, et al. Sweet’s syndrome and malignancy in the UK. Br J Dermatol 1997;137:609-613.

5. Cohen PR, Kurzrock R. Sweet’s syndrome and cancer. Clin Dermatol 1993;11:149-157.

6. Magro CM, Moraes E, Burns F. Sweet’s syndrome in the setting of CD34-positive acute myelogenous leukemia treated with granulocyte colony stimulating factor: evidence for a clonal neutrophilic dermatosis. J Cutan Pathol 2001;28:90-96.

7. Yan ZS, Li DP, Jiang EL, et al. Development of Sweet syndrome in an acute promyelocyte leukemia patient during treatment with all-trans retinoic acid–case report and literature review. Zhonghua Xue Ye Xue Za Zhi 2007;28:462-465.

8. Evans AV, Sabroe RA, Liddell K, Russell-Jones R. Lymphocytic infiltrates as a presenting feature of Sweet’s syndrome with myelodysplasia and response to cyclophosphamide. Br J Dermatol 2002;146:1087-1090.

9. Anavekar NS, Williams R, Chong AH. Sweet’s syndrome in an Australian hospital: a retrospective analysis. Australian J Dermatol 2007;48:161-164.

10. Rondina A, Watson AC. Bullous Sweet’s syndrome and pseudolymphoma precipitated by IL-2 therapy. Cutis 2010;85:206-213.

11. Urano Y, Miyaoka Y, Kosaka M, Kabe K, et al. Sweet’s syndrome associated with chronic myelogenous leukemia: demonstration of leukemic cells within a skin lesion. J Am Acad Dermatol 1999;40:275-279.

12. Ginarte M, Garcia-Doval I, Toribio J. Sweet’s syndrome: a study of 16 cases. Medicinia Clinica Barcelona 1997;109:588-591.

13. Paydas S, Sahin B, Zorludemir S. Sweet’s syndrome accompanying leukaemia: seven cases and review of the literature. Leukemia Research 2000;24:83-86.

14. Disel U, Paydas S, Yavuz S, Tuncer I, Alpay R. Bilateral ear Sweet’s syndrome in a case with relapse acute myeloblastic leukemia. Leukemia Research 2006;30:364.

15. Choi HJ, Chang SE, Lee MW, Choi JH, et al. Case of recurrent Sweet’s syndrome in an 80-year-old man: a clue to an underlying malignancy. Int J Dermatol 2006;45:457-459.

16. Morgan KW, Callen JP, Kentucky L. Sweet’s syndrome in acute myelogenous leukemia presenting as periorbital cellulitis with an infiltrate of leukemic cells. J Am Acad Dermatol 2001;45:590-595.